The table below includes information related to stock options and warrants that were outstanding at the end of each respective the three and nine months ended September 30, 2025 and September 30, 2024. For periods in which the Company incurred a net loss, these options and warrants are not included in weighted average dilutive shares because their impact would be anti-dilutive. For the nine months ended September 30, 2025 and 2024, there were approximately 2,613,240 and 1,024,469 options with a strike price

greater than the average share price for the respective periods, which have been excluded from the weighted average shares because including them would have been antidilutive under the treasury method.